ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

Clinical trial NCT01589146 · UNKNOWN

Trial details

NCT number: NCT01589146
Sponsor: University Of Perugia
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

The Primary Study Objective is to Assess the Efficacy and Safety of Extended 4-week Heparin Prophylaxis Compared to Prophylaxis Given for 8±2 Days After Planned Laparoscopic Surgery for Colorectal Cancer.The Clinical Benefit Will be Evaluated as the Difference in the Incidence of VTE or VTE-related Death Occurring Within 30 Days From Surgery in the Two Study Groups.

Start date: 2010-09-01
Primary completion: 2012-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.